CN1294013A - Medicine for treating prostatic hyperplasia - Google Patents

Medicine for treating prostatic hyperplasia Download PDF

Info

Publication number
CN1294013A
CN1294013A CN99123036A CN99123036A CN1294013A CN 1294013 A CN1294013 A CN 1294013A CN 99123036 A CN99123036 A CN 99123036A CN 99123036 A CN99123036 A CN 99123036A CN 1294013 A CN1294013 A CN 1294013A
Authority
CN
China
Prior art keywords
radix
chinese medicine
medicine preparation
prostatic hyperplasia
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN99123036A
Other languages
Chinese (zh)
Other versions
CN1085097C (en
Inventor
马俊杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99123036A priority Critical patent/CN1085097C/en
Publication of CN1294013A publication Critical patent/CN1294013A/en
Application granted granted Critical
Publication of CN1085097C publication Critical patent/CN1085097C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine in the form of particles for treating prostatic hyperplasia and prostatitis is prepared from astragalus root, Chinese angelica root and chicken's gizzard-skin through washing, backing, polverizing and granulating. Its advantages include high curative rate, quickly taking its effect and short course of treatment.

Description

The medicine of treatment prostatic hyperplasia
The present invention relates to the field of Chinese medicines, especially a kind of prostatic hyperplasia, prostatitic Chinese medicine preparation of being used for the treatment of.
Prostatic hyperplasia (hypertrophy), prostatitis are common person in middle and old age's andropathys, and cardinal symptom is: urgent micturition, frequent micturition, dysurea.This disease can be brought inconvenience and misery to patient's life.Medicine commonly used at present has " bamboo grove peace ", " QIANLIEKANG ", " prostate disease ", " Prostat " and various Chinese medicine preparation etc.Bad during these curative effect of medication fashions, the course of treatment is often longer, and clinical cure rate is low, and the need that have are month after month taken throughout the year, and curative effect is also not remarkable.Current, this disease sickness rate obviously is the gesture of rising, and a patient hastens forward urgent need good effect, the medicine appearance that cure rate is high the age.
The object of the present invention is to provide a kind of treatment prostatic hyperplasia, prostatitic medicine, its short treating period, instant effect, cure rate height.
Technical scheme of the present invention is: it adopts pure Chinese medicinal preparation, medicine comprises: Radix Astragali, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Endothelium Corneum Gigeriae Galli, Rhizoma Atractylodis Macrocephalae, crust halberd, processed with vinegar Rhizoma Corydalis, Radix Notoginseng, Fructus Forsythiae, Hirudo, Olibanum, parasitism, Myrrha, the Radix Rehmanniae, gun additioner, big gun Squama Manis, Radix Adenophorae (Radix Glehniae), Carapax Trionycis (processed with vinegar), roasting Gekko Swinhonis, Concha Ostreae, Fructus Arctii, Fructus Aurantii (parched), succinum, Cornu Cervi Degelatinatum, and the content of various medicines is respectively:
Radix Astragali 1-10% Endothelium Corneum Gigeriae Galli 1-10% processed with vinegar Rhizoma Corydalis 1-10% Hirudo 1-10%
Radix Angelicae Sinensis 1-10% Rhizoma Atractylodis Macrocephalae 1-10% Radix Notoginseng 1-10% Olibanum 1-10%
The parasitic 1-5% of Rhizoma Chuanxiong 1-5% crust halberd 1-5% Fructus Forsythiae 1-5%
Myrrha 1-10% gun additioner 1-10% Radix Adenophorae (Radix Glehniae) 1-10% Concha Ostreae 1-10%
Radix Rehmanniae 1-10% big gun Squama Manis 1-10% Carapax Trionycis (processed with vinegar) 1-10% roasting Gekko Swinhonis 1-10%
Succinum 1-10% Fructus Arctii 1-10% Fructus Aurantii (parched) 1-10% Cornu Cervi Degelatinatum 1-10%
Preparation technology of the present invention:
1, clean: the medical material that will clean washes.
2, oven dry: all medical materials are dried with equipment.
3, pulverize: will dry the back pulverizing medicinal materials.
4, granulate: the medical material of pulverizing is made dissolved granule.
5, packing: with the medicine weighing and bagging that machines.
Embodiments of the invention:
Embodiment 1 each explosive component content
Radix Astragali 4.5% Endothelium Corneum Gigeriae Galli 4.5% processed with vinegar Rhizoma Corydalis 4.5% Hirudo 4.5%
Radix Angelicae Sinensis 4.5% Rhizoma Atractylodis Macrocephalae 4.5% Radix Notoginseng 4.5% Olibanum 4.5%
Rhizoma Chuanxiong 2.5% crust halberd 2.5% Fructus Forsythiae 2.5% parasitism 2.5%
Myrrha 4.5% gun additioner 4.5% Radix Adenophorae (Radix Glehniae) 4.5% Concha Ostreae 4.5%
The Radix Rehmanniae 4.5% big gun Squama Manis 4.5% processed with vinegar turtle 4.5% roasting Gekko Swinhonis 4.5%
Succinum 4.5% Fructus Arctii 4.5% Fructus Aurantii (parched) 4.5% Cornu Cervi Degelatinatum 4.5%
Present embodiment preparation technology:
1, clean: the medical material that will clean washes.
2, oven dry: all medical materials are dried with equipment.
3, powder process: will dry the back pulverizing medicinal materials.
4, granulate: the medical material of pulverizing is made dissolved granule.
5, packing: with the medicine weighing and bagging that machines.
Embodiment two: each explosive component content
Radix Astragali 4% Endothelium Corneum Gigeriae Galli 4% processed with vinegar Rhizoma Corydalis 4% Hirudo 4%
Radix Angelicae Sinensis 4% Rhizoma Atractylodis Macrocephalae 4% Radix Notoginseng 4% Olibanum 4%
Rhizoma Chuanxiong 2% crust halberd 2% Fructus Forsythiae 2% parasitism 2%
Myrrha 5% gun additioner 5% Radix Adenophorae (Radix Glehniae) 5% Concha Ostreae 5%
The Radix Rehmanniae 5% big gun Squama Manis 5% Carapax Trionycis (processed with vinegar) 5% roasting Gekko Swinhonis 5%
Succinum 5% Fructus Arctii 5% Fructus Aurantii (parched) 5% Cornu Cervi Degelatinatum 5%
Present embodiment preparation technology is identical with embodiment one
Embodiment three: each explosive component content
Radix Astragali 4.8% Endothelium Corneum Gigeriae Galli 4.8% processed with vinegar Rhizoma Corydalis 4.8% Hirudo 4.8%
Radix Angelicae Sinensis 4.8% Rhizoma Atractylodis Macrocephalae 4.8% Radix Notoginseng 4.8% Olibanum 4.8%
Rhizoma Chuanxiong 1% crust halberd 1% Fructus Forsythiae 1% parasitism 1%
Myrrha 4.8% gun additioner 4.8% Radix Adenophorae (Radix Glehniae) 4.8% Concha Ostreae 4.8%
The Radix Rehmanniae 4.8% big gun Squama Manis 4.8% Carapax Trionycis (processed with vinegar) 4.8% roasting Gekko Swinhonis 4.8%
Succinum 4.8% Fructus Arctii 4.8% Fructus Aurantii (parched) 4.8% Cornu Cervi Degelatinatum 4.8%
Present embodiment preparation technology is identical with embodiment one
This medicine is a hereditary recipe, and the inventor is in clinical practice for many years, and with these powdered medicine treatment prostatic hyperplasia 342 examples, this powder is by name: infirmity must leading to.All case Jun Jing city hospital at county level ultrasound diagnosis are confirmed as prostatic hyperplasia in conjunction with clinical symptoms, and wherein the age reckling is 28 years old, the maximum 76 years old, 54 years old mean age, course of disease 1-3 person 156 examples, 4-10 person's 132 examples, person's 54 examples more than 10 years.
The course of treatment standard: (one) clinical recovery, sings and symptoms all disappears, and does not recur, ultrasound diagnosis, prostatic hyperplasia part almost disappears or recovers normal.
(2) take a turn for the better: symptom and sign disappears substantially, does not have recurrence, ultrasound diagnosis, and hypertrophy is partly dwindled more than 1/2 or 2/3.
After using the treatment of this medicine, stop using without exception other any medicine and therapy are thrown the treatment of " infirmity must leading to " powder, cured person the shortest course of treatment of treatment time, the longest six courses of treatment, average three courses of treatment, clinical cure rate reaches 82%, improvement rate 16%, total effective rate reaches 100%, hypertrophy part is dwindled significantly or recovers normally frequent micturition, urgent micturition, cardinal symptoms such as dysurea disappear thereupon.
Curative effect of the present invention is showed by model case.
Li Zengsheng: 68 years old, the Hongshan District people of Chifeng.1989 at Chifeng City hospital hospitalization prostatic hyperplasia, clinical symptoms: frequent micturition, urgent micturition, dysurea.It is invalid to take other medicines, changes clothes powder of the present invention in June, 1998, heals entirely after two courses of treatment.
Zhang Yumin: 61 years old, the Songshan District people of Chifeng.Ultrasound diagnosis is diagnosed as prostatic hyperplasia, and it is invalid to take medicines such as " QIANLIEKANG ", uses powder of the present invention instead, recovery from illness two courses of treatment, and it is normal that the ultrasound diagnosis prostate recovers.
Open and send out: 28 years old, the Ning Dixian people of Chifeng.Suffer from prostatitis, take powder symptom one course of treatment of the present invention and subtract greatly, recovery from illness two courses of treatment is followed up a case by regular visits to after 1 year and is not had recurrence.
Guo Yaguang: 30 years old, people from Aohan Banner, Chifeng, gold mine workman.Nineteen ninety-five was once suffered from prostatitis, after take Chinese medicine and western medicine and cure, because underground work toils away, humidity, mining area hospital in 1996 ultrasound diagnosis is diagnosed as prostatic hyperplasia, it is invalid to take a large amount of Chinese medicines and " prostate disease " medicine of etc.ing, rises in August, 1997 and obeys one course of treatment of powder of the present invention, and symptom is clearly better, symptom complete obiteration two courses of treatment, ultrasound diagnosis recover normal.

Claims (2)

1, a kind of Chinese medicine preparation for the treatment of prostatic hyperplasia, it is characterized in that: the prescription of this Chinese medicine preparation is:
Radix Astragali 1-10% Endothelium Corneum Gigeriae Galli 1-10% processed with vinegar Rhizoma Corydalis 1-10% Hirudo 1-10%
Radix Angelicae Sinensis 1-10% Rhizoma Atractylodis Macrocephalae 1-10% Radix Notoginseng 1-10% Olibanum 1-10%
The parasitic 1-5% of Rhizoma Chuanxiong 1-5% crust halberd 1-5% Fructus Forsythiae 1-5%
Myrrha 1-10% gun additioner 1-10% Radix Adenophorae (Radix Glehniae) 1-10% Concha Ostreae 1-10%
Radix Rehmanniae 1-10% big gun Squama Manis 1-10% Carapax Trionycis (processed with vinegar) 1-10% roasting Gekko Swinhonis 1-10%
Succinum 1-10% Fructus Arctii 1-10% Fructus Aurantii (parched) 1-10% Cornu Cervi Degelatinatum 1-10%
2, Chinese medicine preparation according to claim 1 is characterized in that:
The preparation technology of this Chinese medicine preparation is:
(1) cleans: need clean medical material and wash.
(2) oven dry: all medical materials are dried with equipment.
(3) pulverize: the pulverizing medicinal materials after will drying.
(4) granulate: the medical material of pulverizing is made dissolved granule.
(5) packing: with the medicine weighing and bagging that machines.
CN99123036A 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia Expired - Fee Related CN1085097C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99123036A CN1085097C (en) 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99123036A CN1085097C (en) 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia

Publications (2)

Publication Number Publication Date
CN1294013A true CN1294013A (en) 2001-05-09
CN1085097C CN1085097C (en) 2002-05-22

Family

ID=5282748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99123036A Expired - Fee Related CN1085097C (en) 1999-10-26 1999-10-26 Medicine for treating prostatic hyperplasia

Country Status (1)

Country Link
CN (1) CN1085097C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790464B2 (en) * 2003-01-16 2004-09-14 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions
CN100342888C (en) * 2005-03-14 2007-10-17 庹元斌 Chinese medicine preparation for treating prostatic hyperplasia
CN101461841B (en) * 2009-01-09 2011-02-16 黄卫忠 Chinese patent medicine for treating prostatoplasia
CN101579412B (en) * 2008-05-15 2011-04-20 北京北大维信生物科技有限公司 Medicinal composition for treating prostatauxe and preparation method thereof
CN101647946B (en) * 2009-08-21 2011-10-26 李丹 Hyperplasia-ablating pill for treating prostate hyperplasia

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI693938B (en) * 2019-06-12 2020-05-21 康品科技有限公司 Use of burdock extract

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1057453C (en) * 1995-10-23 2000-10-18 张克忠 Tongniaoling for diuresis
CN1063054C (en) * 1996-06-29 2001-03-14 郭万启 Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790464B2 (en) * 2003-01-16 2004-09-14 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions
CN100342888C (en) * 2005-03-14 2007-10-17 庹元斌 Chinese medicine preparation for treating prostatic hyperplasia
CN101579412B (en) * 2008-05-15 2011-04-20 北京北大维信生物科技有限公司 Medicinal composition for treating prostatauxe and preparation method thereof
CN101461841B (en) * 2009-01-09 2011-02-16 黄卫忠 Chinese patent medicine for treating prostatoplasia
CN101647946B (en) * 2009-08-21 2011-10-26 李丹 Hyperplasia-ablating pill for treating prostate hyperplasia

Also Published As

Publication number Publication date
CN1085097C (en) 2002-05-22

Similar Documents

Publication Publication Date Title
CN1099983A (en) Medicine for treating rheumatoid or rheumatic arthritis and hyperosteogeny, and method for preparing same
CN1294013A (en) Medicine for treating prostatic hyperplasia
CN1085099C (en) Medicine for treating thyroid enlargement and thyroidism
CN101342338B (en) Medicament for treating hepatopathy
CN1166388C (en) Medicine for treating nosal inflammation
CN1943764A (en) The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer
CN1490017A (en) Medicines against rheunatoid and rheumatic diseases
CN1389255A (en) Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis
CN1111046C (en) Chinese medicine preparation for curing postpartum disease of woman
CN101658585A (en) Application of Chinese medicinal composition in preparing medicament for treating nasosinusitis
CN1056770C (en) Heat-clearing plaque-eliminating bolus for curing psoriasis
CN1814153A (en) Medicine composition for preventing and treating breast cancer and preparing method
CN101450187A (en) Medicine composition for treating asthma
CN101007113B (en) Shenling Chinese medicine preparation for treating acute and chronic hepatitis and its preparation method
CN1183986A (en) Chinese medicine Pingguxiaociwan for curing Bi-syndrome
CN1085098C (en) Medicine for treating mastoplasia
CN1253017A (en) Medicine for treating appendicitis
CN100396323C (en) Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof
CN1056289C (en) Antiphthitic medicine
CN1159057C (en) Medicine for treating hepatitis, and preparing process thereof
CN1772213A (en) Face nursing and beautifying Chinese medicine composition and its prepn
CN101450133A (en) Medicine for treating abdominopelvic cavity disease postoperative intestinal adhesion
CN1101208C (en) Medicine for treating uninary calculaus and its preparing process
CN1225838A (en) Medicinal liquor for treating hypertension
CN1130220C (en) Chinese medicine 'Shexianfengshi wan'

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
BB1A Publication of application
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee